← All companies

SPRY

ARS Pharmaceuticals, Inc.

SPRY Nasdaq Pharmaceutical Preparations EDGAR ↗

$5.46

-0.17 -3.02%

Key statistics

from XBRL data in SEC filings

Market cap

$542M

Revenue (TTM)

$99.0M

Net income (TTM)

-$198M

EPS (TTM)

$-2.00

P/E ratio

—

Dividend yield

—

Free cash flow

-$171M

Cash

$24.3M

Total assets

$288M

Gross margin

—

52-week range

$4.91 – $18.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 17, 2026 8-K Director or officer change Jul 7, 2026 8-K Shareholder vote results Jun 25, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2026 8-K Director or officer change May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 9, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 10, 2025 8-K Entered a material agreement; Took on a direct financial obligation Sep 29, 2025 8-K Other events Aug 28, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 13, 2025 8-K Shareholder vote results Jun 26, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Entered a material agreement May 2, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Other events Mar 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 10-Q/A Quarter ended 2024-09-30 Dec 6, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Entered a material agreement Nov 12, 2024 8-K Entered a material agreement Oct 15, 2024 8-K Entered a material agreement Sep 23, 2024 8-K Regulation FD disclosure; Other events Aug 12, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Regulation FD disclosure Jun 28, 2024 8-K Regulation FD disclosure; Other events Jun 28, 2024 8-K Shareholder vote results Jun 21, 2024 8-K Regulation FD disclosure May 10, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Results of operations (earnings release) Mar 21, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 7, 2024